{"id":"W2999077673","doi":"10.1016/s0923-7534(19)66474-4","title":"O-0009 Second Line Therapy in Hepatocellular Carcinoma (HCC): A Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Hepatocellular carcinoma; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397668,0.001430115,0.002734056,0.0003039336,0.0004069766,0.0008671779,0.0006011159,0.00141769,0.009492104],"category_scores_gemma":[0.001634257,0.0005872194,0.002348254,0.0003405133,0.0007927264,0.0009582881,0.0004579463,0.003025353,0.001091094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007231171,"about_ca_system_score_gemma":0.0009726542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001952447,"about_ca_topic_score_gemma":0.003464462,"domain_scores_codex":[0.9993943,0.0003547545,0.0000379976,0.00009514719,0.00003071829,0.00008707665],"domain_scores_gemma":[0.99924,0.0002125265,0.0001867194,0.00006723041,0.00005016249,0.0002432356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9854931,0.002374754,0.0004742229,0.0006989835,0.001414113,0.00002199129,0.00002640888,0.0001283214,0.0009056744,0.00006123262,0.0005736952,0.007827531],"study_design_scores_gemma":[0.9717529,0.02572876,0.001139419,0.00003559386,0.0007115793,0.00001570544,0.0000170541,0.0001049179,0.000109399,0.00004483299,0.0003333663,0.000006552256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799485,0.00896149,0.0006421735,0.001272375,0.001057512,0.003629341,0.001404573,0.0001505514,0.002933409],"genre_scores_gemma":[0.9835321,0.004794387,0.001430518,0.001446289,0.0005864975,0.003598538,0.001241416,0.00002607671,0.003344155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009492104,"threshold_uncertainty_score":0.03175426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1417281524955682,"score_gpt":0.3679942408696421,"score_spread":0.2262660883740739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}